Home/Filings/4/0001104659-21-061217
4//SEC Filing

Egorov Georgy 4

Accession 0001104659-21-061217

CIK 0001828185other

Filed

May 3, 8:00 PM ET

Accepted

May 4, 8:22 PM ET

Size

8.0 KB

Accession

0001104659-21-061217

Insider Transaction Report

Form 4
Period: 2021-04-29
Egorov Georgy
Chief Financial Officer
Transactions
  • Award

    Share Option (Right to Buy)

    2021-04-29+6,9186,918 total
    Exercise: $17.00Exp: 2031-04-29Ordinary Shares (6,918 underlying)
  • Award

    Share Option (Right to Buy)

    2021-04-29+149,865149,865 total
    Exercise: $17.00Exp: 2031-04-29Ordinary Shares (149,865 underlying)
Footnotes (3)
  • [F1]This option shall vest and become exercisable on April 29, 2022.
  • [F2]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
  • [F3]This option shall vest and become exercisable in three equal annual installments, with the first installment vesting on April 29, 2022.

Issuer

Vaccitech plc

CIK 0001828185

Entity typeother

Related Parties

1
  • filerCIK 0001851623

Filing Metadata

Form type
4
Filed
May 3, 8:00 PM ET
Accepted
May 4, 8:22 PM ET
Size
8.0 KB